+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Amarogentin

BP1603
21018-84-8
98%
Phytounique
Amarogentin incorporated in liposomes or niosomes may have clinical application in the treatment of leishmaniasis. It plays cemopreventive/therapeutic role during liver carcinogenesis through modulation of cell cycle and apoptosis. Amarogentin may offer therapeutic potential for preventing or treating thromboembolic disorders, it prevents platelet activation through the inhibition of PLC γ2-PKC cascade and MAPK pathway. Amarogentin is a secoiridoid glycoside that consists of (4aS,5R,6R)-5-ethenyl-6-hydroxy-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-1-one having a 2-O-[(3,3',5-trihydroxybiphenyl-2-yl)carbonyl]-beta-D-glucopyranosyl group attached at position 6 via a glycosidic linkage. It has a role as a metabolite and an EC 5.99.1.2 (DNA topoisomerase) inhibitor. It is a secoiridoid glycoside and a monosaccharide derivative.
Catalog No Package Original Price Price Inventory Quantity Operating
BP1603-20mg 20mg
BP1603-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Amarogentin Related Products

Product drug property prediction parameters

  • 201.6700

  • 1.2493

  • 1.1698

  • 1.6783

  • .5349

  • .2696

  • Low

  • 84.7466

  • 4.9081

  • No

  • No

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • Yes

  • Yes

  • Yes